Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,250,725 papers from all fields of science
Search
Sign In
Create Free Account
Anionic Lipopeptides
Known as:
Anionic Lipopeptide
, Lipopeptide, Anionic
, Lipopeptides, Anionic
Lipopeptides with an anionic peptide scaffold.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Lipopeptides
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Cytosolic delivery of inhibitory antibodies with cationic lipids
H. Wang
,
A. Tsourkas
Proceedings of the National Academy of Sciences…
2019
Corpus ID: 204703948
Significance Antibodies are important research tools because they can be developed to bind to as well as directly inhibit almost…
Expand
2019
2019
Structure-activity relationship of group A streptococcus lipopeptide vaccine candidates in trimethyl chitosan-based self-adjuvanting delivery system.
Reshma J. Nevagi
,
Wei Dai
,
+4 authors
I. Toth
European journal of medicinal chemistry
2019
Corpus ID: 195764978
2017
2017
Interaction of the Lipopeptide Biosurfactant Lichenysin with Phosphatidylcholine Model Membranes.
Jonathan R Coronel
,
A. Marqués
,
Á. Manresa
,
F. Aranda
,
J. Teruel
,
A. Ortiz
Langmuir
2017
Corpus ID: 33243030
Lichenysins produced by Bacillus licheniformis are anionic lipopeptide biosurfactants with cytotoxic, antimicrobial, and…
Expand
Highly Cited
2016
Highly Cited
2016
Molecular Bases Determining Daptomycin Resistance-Mediated Resensitization to β-Lactams (Seesaw Effect) in Methicillin-Resistant Staphylococcus aureus
A. Renzoni
,
W. Kelley
,
+9 authors
A. Rosato
Antimicrobial Agents and Chemotherapy
2016
Corpus ID: 4795759
ABSTRACT Antimicrobial resistance is recognized as one of the principal threats to public health worldwide, yet the problem is…
Expand
2015
2015
Pam2 lipopeptides systemically increase myeloid-derived suppressor cells through TLR2 signaling.
Akira Maruyama
,
H. Shime
,
Yohei Takeda
,
M. Azuma
,
M. Matsumoto
,
T. Seya
Biochemical and Biophysical Research…
2015
Corpus ID: 32038182
Review
2012
Review
2012
Daptomycin: a review of properties, clinical use, drug delivery and resistance.
C. Vilhena
,
Ana Bettencourt
Mini-Reviews in Medical Chemistry
2012
Corpus ID: 21395611
Daptomycin is a branched cyclic anionic lipopeptide antibiotic that was discovered in the early 1980's but got the FDA approval…
Expand
2011
2011
Soluble Proteins Induce Strong CD8+ T Cell and Antibody Responses through Electrostatic Association with Simple Cationic or Anionic Lipopeptides That Target TLR2
B. Chua
,
David Pejoski
,
S. Turner
,
W. Zeng
,
D. Jackson
Journal of Immunology
2011
Corpus ID: 207425621
The low immunogenicity exhibited by most soluble proteins is generally due to the absence of molecular signatures that are…
Expand
2011
2011
An artificial intelligence approach to Bacillus amyloliquefaciens CCMI 1051 cultures: application to the production of anti-fungal compounds.
A. T. Caldeira
,
J. Arteiro
,
J. Roseiro
,
J. Neves
,
H. Vicente
Bioresource Technology
2011
Corpus ID: 39616015
Highly Cited
2008
Highly Cited
2008
Effect of divalent cations on the structure of the antibiotic daptomycin
S. W. Ho
,
David Jung
,
+5 authors
S. Straus
European Biophysics Journal
2008
Corpus ID: 9129322
Daptomycin, a cyclic anionic lipopeptide antibiotic, whose three-dimensional structure was recently solved using solution state…
Expand
Highly Cited
2004
Highly Cited
2004
Reaction of bis(2,4-dinitrophenyl) phosphate with hydrazine and hydrogen peroxide. Comparison of O- and N- phosphorylation.
J. Domingos
,
Elisane Longhinotti
,
+4 authors
F. Nome
Journal of Organic Chemistry
2004
Corpus ID: 29958776
Nonionic hydrazine reacts with anionic bis(2,4-dinitrophenyl) phosphate (BDNPP), giving 2,4-dinitrophenyl hydrazine and dianionic…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE